Chinot OL, Cloughesy T, Henrikson R, et al: Efficacy and safety of bevacizumab plus standard combination temozolomide and radioyherapy in newly diagnosed glioblastoma: final results from AVAglio. ECC2013, Abstract No. 3301
Friedman HS, Prados MD, Wen PY, et al: Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 28: 4733-40, 2009
Gordon MS, Margolin K, Talpaz M, et al: Phase I safety and pharmacokinetic study of recombinant human anti- vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 19: 843-50, 2001
Herrlinger U, Schaefer N, Steinbach JP, et al: Bevacizumab, irinotecan and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: Updated results from the randomized multicenter GLARIUS trial. Program and abstracts of the European Cancer Congress 2013; Abstract 3300